The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Mayo Clinic
NeoImmuneTech
Genmab
Seagen Inc.
Tizona Therapeutics, Inc
Institute of Cancer Research, United Kingdom
Eli Lilly and Company
Seagen Inc.
Novartis
BicycleTx Limited
Rondo Therapeutics
Maastricht University Medical Center
Merck Sharp & Dohme LLC
Xencor, Inc.
NuCana plc
University Health Network, Toronto
Sotio Biotech Inc.
Sellas Life Sciences Group
Light Chain Bioscience - Novimmune SA
Salubris Biotherapeutics Inc
Adlai Nortye Biopharma Co., Ltd.
ADC Therapeutics S.A.
Pliant Therapeutics, Inc.
Eli Lilly and Company
Hefei TG ImmunoPharma Co., Ltd.
Corvus Pharmaceuticals, Inc.
Xencor, Inc.
Tesaro, Inc.
Incyte Corporation
Eli Lilly and Company
MultiVir, Inc.